Nano Pharmaceuticals
Market Cap
₹127 ₹127 Cr.
P/E
18.26
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
1.08
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
32.89 %
Institutions
Institutions
0.62 %
Market cap
Market cap
127 Cr
No. of Shareholders
No. of Shareholders
16,554
OPM (%)
OPM (%)
11.38 %
PE
PE
18.26
Prom Holding
Prom Holding
53.65 %
ROCE (%)
ROCE (%)
14.70
ROE (%)
ROE (%)
8.79
Sales
Sales
170 Cr
  • Lactose (India)
  • Balaxi Pharma.
  • Parnax Lab
Last updated on
      Price Range

      See where the stock is trading versus its 52-week high and low.

      Low
      76
      52W Range
      High
      137
      Timeline

      Key company specific updates.

      Custom financial statement

      Edit rows

      Forensics

      9 Yes

      Positive for this company

      2 Neutral

      Neutral for this company

      6 No

      Negative for this company

      0 No Data

      Insufficient data to analyse

      Revenue mix

      Product Wise Break-Up

      Peer Comparison

      FAQs on Lactose (India) Ltd. Business

      Lactose (India) Limited in Vadodara, Gujarat, ensures only the highest quality products leave its facility, meeting the rigorous standards set by the company and its customers.

      Lactose (India) major competitors are Panchsheel Organics, Kimia Biosciences, Speciality Medicines, Curis Lifesciences, Balaxi Pharma., Quest Laboratories, Vijaypd Ceutical.
      Market Cap of Lactose (India) is ₹127 Crs.
      While the median market cap of its peers are ₹135 Crs.

      Lactose (India) seems to be less financially stable compared to its competitors.
      Altman Z score of Lactose (India) is 2.24 and is ranked 8 out of its 8 competitors.

      Company Filing

      2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
      Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
      Earnings Release
      Investor Presentation
      Conference Call
      Conference Call SummaryCon Call Summary

      Discussions & Analysis

      Ideas Dashboard
      Results
      Timeline
      Watchlist
      Portfolio
      Alerts
      Stock Screener
      Market
      Raw Material